000			05187nam a22003735i 4500
001			82032
003			ES-MaUEC
005			20230207040352.0
007			cr nn 008mamaa
008			141117s2015 xxu| s |||| 0|eng d
020			_a9781493918812
024	7		_a10.1007/978-1-4939-1881-2 _2doi
050		4	_aRC280.B5 _b2015 EB
245	1	0	_aManagement of Bladder Cancer : _bA Comprehensive Text With Clinical Scenarios _cedited by Badrinath R. Konety, Sam S. Chang.
260			_aNew York _bSpringer _c2015
300			_a1 recurso en línea (XX, 479 páginas) _b74 ilustraciones, 68 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aEpidemiology and natural history -- Screening for Bladder Cancer -- Pathology and Staging: Histopathology and Cytopathology -- Pathology and Staging: Genetics and Molecular Biology -- Imaging in Localized and Advanced Bladder Cancer -- New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder -- Socioeconomic issues and improved quality of care -- Quality of life measures -- Prognostication and risk assessment -- Clinical trials and emerging therapeutic strategies in bladder cancer -- Improved diagnostic techniques -- Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging -- Localized surgical therapy and surveillance -- Clinical Scenario: Initial high grade Ta tumor -- Clinical Scenario: Recurrent Ta tumor -- Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor -- Clinical Scenario: Low grade T1 tumor -- Intravesical therapy -- Clinical Scenario: Initial CIS -- Management of BCG Recurrent Bladder Cancer -- Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG -- Maurizio Brausi -- Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation -- Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines -- Open Radical Cystectomy -- Robotic cystectomy -- Clinical Scenario: T2 bladder tumor -- Urinary Diversion: Open and robotic techniques -- Chemoradiotherapy -- Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation -- Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application -- Clinical Scenario: Large volume, non metastatic T2 bladder tumor -- The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer -- Clinical Scenario: Unexpected positive nodes at radical cystectomy -- Surveillance and monitoring -- Clinical Scenario: The Role of Perioperative Chemotherapy -- Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy -- Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU.
520	3		_aThis book provides a single, comprehensive reference source that incorporates the epidemiology, natural history, and the latest genetic and molecular biological findings of bladder cancer. This book discusses the diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer and incorporates the new findings on markers for the diagnosis of bladder cancer. Risk stratified treatment of non-muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline-based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. This book covers the application of chemotherapy for muscle invasive and advanced disease. The evidence-based application of multimodality therapy is highlighted. Gaps in current knowledge and important areas for clinicalÂ{u0CA5}search are highlighted. Authored by experts in their respective fields, Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios serves as an easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		0	_9154421 _aRadiología intervencionista _0
650		7	_aUrología _0 _2embne _9138565
650	2	7	_aUrología _0 _2embne _9138565
700	1		_aKonety, Badrinath R _eeditor literario _992664 _0Local
700	1		_aChang, Sam S. _eeditor literario _0Local _994678
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4939-1881-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12906712 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gxxu _h0
945			_aRC280.B5 M363 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11574409 _z06-04-17
999			_c82032 _d82032 _x1